Ann Arbor, United States
Celsee, Inc., founded in 2010, is strategically positioned at the intersection of biotechnology and innovation. Based in Ann Arbor, Michigan, this privately held company is breaking new ground in single-cell analysis through its unique use of gravity to enhance cell capture and viability rates.
The company’s flagship technology, the Genesis system, offers high-confidence results across various applications including single-cell cytometry, proteogenomics, transcriptomics, and rare-cell enumeration. This is particularly significant as the demand for precision in biological research continues to grow. Celsee's ability to scale easily to millions of cells provides a strong competitive edge, reinforcing their slogan, "Because every cell matters."
Celsee recently received an acquisition investment in April 2020 from Labor Capital, highlighting investor confidence in their cutting-edge solutions and potential for growth in the biotech industry. This positions Celsee as a compelling opportunity for investors aiming to leverage advancements in life sciences.
